1. Home
  2. /
  3. Therapeutic Expertise
  4. /
  5. Cardiovascular and Metabolic Diseases

Cardiovascular and Metabolic Diseases

Accelerating Breakthroughs in Cardiovascular and Metabolic Research

At Lambda Therapeutic Research, we acknowledge the persistent threat of cardiovascular disease, which continues to be the leading cause of mortality globally. Our approach focuses on urgent solutions, combining agility, speed, and data-driven insights to enhance cardiovascular outcomes and elevate the quality of care. Our extensive global experience encompasses early-phase to post-approval studies, covering a wide range of indications, including rare diseases. 

0
Studies
0 +
Patients
0 +
Sites

Our expertise extends to managing various indications, including but not limited to:

In the realm of endocrine and metabolic diseases, including diabetes, dyslipidemia, kidney disease, obesity, and related disorders, Lambda Therapeutic Research is committed to offering innovative and expedited solutions. We go beyond the role of a typical CRO, collaborating closely with innovative companies pioneering endocrine and metabolic drug development. 

Together, we strive to navigate the intricacies of these diseases and collectively address their complex challenges. Our broad experience covers a spectrum of endocrine and metabolic indications.

Our expertise extends to managing various metabolic indications, including but not limited to:

Our Presence

We are aggressively expanding globally and are confident in our research initiatives, propelling us toward a trajectory of excellence.

Corporate Office – Ahmedabad

Lambda House, Plot No. 38,
Survey No. 388,
Near Silver Oak University,
S.G. Highway, Gota, Ahmedabad - 382481,
Gujarat, India.

Representative Office 

Poland (Warsaw)

Representative Office 

UK (London)

Representative Office 

Canada (Toronto)

Representative Office 

Pittsburgh

Representative Office 

US (Las Vegas)

Let's Unveil New Therapies Together

Connect with our experts to leverage our proven track record of clinical research excellence.